https://www.selleckchem.com/pr....oducts/nedisertib.ht
INTRODUCTION The characteristics, prognostic factors, and management of duodenal neuroendocrine neoplasms (dNEN) are ill-defined given their rarity. Whether non-surgical management could be appropriate in good-prognosis non-metastatic dNEN, as for pancreatic NEN (pNEN), is unknown. We aimed to describe the management and prognosis of non-metastatic dNEN patients. METHODS All consecutive patients with non-metastatic dNEN managed between 1981 and 2018 in two expert centers were included. Recurrence-free survival (RFS) and factors assoc
Like
Comment
Share
